174 related articles for article (PubMed ID: 29622276)
21. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life.
Quyn AJ; Solomon MJ; Lee PM; Badgery-Parker T; Masya LM; Young JM
Dis Colon Rectum; 2016 Nov; 59(11):1005-1010. PubMed ID: 27749474
[TBL] [Abstract][Full Text] [Related]
22. Baseline quality of life predicts pelvic exenteration outcome.
Choy I; Young JM; Badgery-Parker T; Masya LM; Shepherd HL; Koh C; Heriot AG; Solomon MJ
ANZ J Surg; 2017 Nov; 87(11):935-939. PubMed ID: 26687437
[TBL] [Abstract][Full Text] [Related]
23. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
Mourton SM; Chi DS; Sonoda Y; Alektiar KM; Venkatraman ES; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800
[TBL] [Abstract][Full Text] [Related]
24. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
[TBL] [Abstract][Full Text] [Related]
25. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
26. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
27. The effect of body mass index on surgical outcomes and survival following pelvic exenteration.
Iglesias DA; Westin SN; Rallapalli V; Huang M; Fellman B; Urbauer D; Frumovitz M; Ramirez PT; Soliman PT
Gynecol Oncol; 2012 May; 125(2):336-42. PubMed ID: 22261299
[TBL] [Abstract][Full Text] [Related]
28. Pelvic exenteration: effects of surgery on quality of life and body image--a prospective longitudinal study.
Hawighorst-Knapstein S; Schönefussrs G; Hoffmann SO; Knapstein PG
Gynecol Oncol; 1997 Sep; 66(3):495-500. PubMed ID: 9299266
[TBL] [Abstract][Full Text] [Related]
29. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy.
Young JM; Badgery-Parker T; Masya LM; King M; Koh C; Lynch AC; Heriot AG; Solomon MJ
Br J Surg; 2014 Feb; 101(3):277-87. PubMed ID: 24420909
[TBL] [Abstract][Full Text] [Related]
30. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.
Benn T; Brooks RA; Zhang Q; Powell MA; Thaker PH; Mutch DG; Zighelboim I
Gynecol Oncol; 2011 Jul; 122(1):14-8. PubMed ID: 21444105
[TBL] [Abstract][Full Text] [Related]
31. Pelvic exenteration.
Barber HR
Cancer Invest; 1987; 5(4):331-8. PubMed ID: 3311312
[TBL] [Abstract][Full Text] [Related]
32. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
[TBL] [Abstract][Full Text] [Related]
33. Quality of life and functional outcomes following pelvic exenteration and sacrectomy.
McCarthy ASE; Solomon MJ; Koh CE; Firouzbakht A; Jackson SA; Steffens D
Colorectal Dis; 2020 May; 22(5):521-528. PubMed ID: 31850656
[TBL] [Abstract][Full Text] [Related]
34. Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.
Lakhman Y; Nougaret S; Miccò M; Scelzo C; Vargas HA; Sosa RE; Sutton EJ; Chi DS; Hricak H; Sala E
Radiographics; 2015; 35(4):1295-313. PubMed ID: 26172364
[TBL] [Abstract][Full Text] [Related]
35. Sexual Health Before Treatment in Women with Suspected Gynecologic Malignancy.
Bretschneider CE; Doll KM; Bensen JT; Gehrig PA; Wu JM; Geller EJ
J Womens Health (Larchmt); 2017 Dec; 26(12):1326-1332. PubMed ID: 28829666
[TBL] [Abstract][Full Text] [Related]
36. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
37. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration.
Ratliff CR; Gershenson DM; Morris M; Burke TW; Levenback C; Schover LR; Mitchell MF; Atkinson EN; Wharton JT
Cancer; 1996 Nov; 78(10):2229-35. PubMed ID: 8918419
[TBL] [Abstract][Full Text] [Related]
38. Overall survival after pelvic exenteration for gynecologic malignancy.
Westin SN; Rallapalli V; Fellman B; Urbauer DL; Pal N; Frumovitz MM; Ramondetta LM; Bodurka DC; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Sep; 134(3):546-51. PubMed ID: 25014540
[TBL] [Abstract][Full Text] [Related]
39. Pelvic exenterations for gynecologic cancers: A retrospective analysis of a 30-year experience in a cancer center.
Knight S; Lambaudie E; Sabiani L; Mokart D; Provansal M; Tallet A; Houvenaeghel G
Eur J Surg Oncol; 2018 Dec; 44(12):1929-1934. PubMed ID: 30262326
[TBL] [Abstract][Full Text] [Related]
40. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
